Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2015
Event: Receipt of a subpoena by JSA HealthCare Corporation, a subsidiary of DaVita's HealthCare Partners division.
Financial Metrics
This filing is a current report regarding a legal event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses a new legal contingency involving a government investigation.
Outlook, Risks, and Contingencies
- Subpoena Details: On March 13, 2015, JSA HealthCare Corporation received a subpoena from the Office of Inspector General, U.S. Department of Health and Human Services.
- Investigation Scope: The subpoena relates to an ongoing civil investigation concerning Humana's and its service providers' risk adjustment practices and data. This includes the identification and verification of patient diagnoses and factors used in making those diagnoses.
- Time Period: The request covers documents and information from January 1, 2008, through December 31, 2013.
- Specific Focus: The request targets all Humana Medicare Advantage Plans for which JSA provided services, including communications regarding patient diagnoses and specific contracts with two Florida physicians.
- Management Response: The Company intends to cooperate with the investigation and plans to meet with government representatives to discuss the scope of the subpoena and document production.
Key Facts for Investor Verification
- Verify the potential financial impact of the ongoing civil investigation regarding Humana's risk adjustment practices.
- Monitor future filings for updates on the scope of the subpoena and the outcome of the investigation.
- Assess whether the investigation into JSA's services for Humana Medicare Advantage Plans could lead to penalties or operational restrictions.